We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nanoco Group Plc | LSE:NANO | London | Ordinary Share | GB00B01JLR99 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.49 | -2.53% | 18.86 | 18.74 | 18.98 | 19.02 | 18.98 | 19.00 | 590,303 | 16:35:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 5.62M | 11.09M | 0.0343 | 5.53 | 61.38M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/5/2017 13:34 | Even if paid for, it should be unbiased and accurate. A client can check it for errors, but cannot change it, or prevent its publication. For Nano, it’s the best thing they could do for PR and marketing, while waiting for their first sell. Which will eventually happen :) | balaura | |
11/5/2017 13:11 | Fair enough, SteMis. But what it clearly doesn't say is that the company is having to face coming to the end of the road and shut up shop! | aimingupward2 | |
11/5/2017 12:49 | Bagpuss - possibly. I wasn't implying anything either way... Aimingupward - I don't think you can really separate Edison's views from those of the management. It's paid for research. Not really independent... I'm interested though why they've decided to pay for research at this point. | stemis | |
11/5/2017 12:35 | So Edison are confidently expecting things to come good for Nano and the share price to more than double over the next two years. Fine. I can live with that. | aimingupward2 | |
11/5/2017 12:29 | All we need now is for ME to BUY some shares, for a change... | nowenterprise | |
11/5/2017 12:27 | Stemis. But if they actually do have a trading business then working capital funding might be available. | bagpuss67 | |
11/5/2017 12:13 | Well one thing any true breakout needs is supportive volume. So far so good. | boris cobaka | |
11/5/2017 11:53 | The Edison report is interesting because, as paid for (by Nanoco) research, it almost certainly reflects the current views of the management. They expect to lose £4m in the second half of the year and the cash to fall to £6.4m (from £8.3m at half year). The following year they expect to breakeven but net cash to fall to £3.3m as working capital sucks up cash. What would be interesting is a split of 2018 as I'm guessing they'll still be losing money in the first half of the year. | stemis | |
11/5/2017 11:52 | Added to header , cheers | mr.oz | |
11/5/2017 11:42 | thanks rat. | bagpuss67 | |
11/5/2017 11:11 | Just seen the two massive buys today! Looking good :) | balaura | |
11/5/2017 11:08 | Thank you rat...and Edison. The best and most comprehensive report I've seen so far. | balaura | |
11/5/2017 10:45 | Updated report from Edison www.edisoninvestment | rat attack | |
11/5/2017 10:40 | Are Merck shipping, or marketing CFQDs now? Market rumour or official? I assume via Runcorn supply, or do they have a mini lab running for sampling | luxaeterna1 | |
11/5/2017 10:29 | "Marketing" is still excellent news. A company like Merck don't market something if they don't believe in it. | woody33 | |
11/5/2017 08:29 | ? Is this new? Their release said marketing?? | bagpuss67 | |
11/5/2017 08:13 | Great news that Merck are now shipping CFQDs - officially | tonsil | |
11/5/2017 08:10 | volumes very low. Anyone know if this is traded on plus? | boris cobaka | |
11/5/2017 05:39 | Tipped - Shares mag. | mirabeau | |
10/5/2017 17:09 | Must be an error, but closed with the ask at 43p. Fun tomorrow if it's correct. | riskblue | |
10/5/2017 11:58 | That's a relief then. | boris cobaka | |
10/5/2017 11:05 | From the rns | bagpuss67 | |
10/5/2017 10:52 | nowent - this mornings rns bagpuss - and you know this how? | boris cobaka | |
10/5/2017 10:46 | Hasn't he just moved some of the Blake holding to a CFD in his own name with no overall reduction? | bagpuss67 | |
10/5/2017 10:43 | Boris, what RNS are you referring to please? | nowenterprise |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions